Physician's Weekly
JUNE 22, 2025
Semi-structured interviews with practice staff were conducted to explore reasons for selecting a specific study arm. The results showed that out of 76 enrolled practices, 46 selected the self-paced approach using the TIPS modules, and 16 of these (35%) included a Diabetes Care and Education Specialist (DCES).
Physician's Weekly
JUNE 22, 2025
These improvements were observed across all subgroups based on left ventricular ejection fraction (LVEF) (≥50% or <50%), BMI (≥35 kg/m 2 or <35 kg/m 2 ), cardiomyopathy type, and diabetes status.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Physician's Weekly
JUNE 22, 2025
Conversely, HFpEF, particularly in individuals with metabolic diseases, such as obesity or type 2 diabetes mellitus, results from both mechanical and metabolic overload. Springer Nature Limited. The post Cardiac intermediary metabolism in heart failure: substrate use, signalling roles and therapeutic targets.
Physician's Weekly
JUNE 17, 2025
As rates of obesity continue to rise alongside new therapeutic options, a team of researchers at the 85th Scientific Sessions of the American Diabetes Association (ADA) will present findings from PATHWEIGH , a pragmatic clinical trial designed to embed evidence-based obesity care directly into primary care workflows.
Physician's Weekly
JUNE 21, 2025
prevalence of MCI in individuals with T2DM. Significant associations were observed with age (OR = 1.06, P = 0.01), female sex (OR = 1.23, P = 0.05), and diabetes duration (OR = 1.07, P = 0.03). 2025.1617248/full The post Multifactorial Drivers of Cognitive Decline in Diabetes first appeared on Physician's Weekly.
Today's Hospitalist
JUNE 7, 2025
THE BLOCKBUSTER GLP-1 receptor agonists are a transformative class of medications increasingly tied to better outcomes across a variety of conditions and organ systems, not just in patients with obesity and type 2 diabetes. They presented a rapid clinical update Webinar in May 2025 hosted by the Society of Hospital Medicine.
Physician's Weekly
JUNE 22, 2025
Data collected included demographics, biochemical markers, genetic profiles, pharmacologic treatments, vital signs at initial presentation, and follow-up information, including survival outcomes. The results showed that 196 individuals with PPGLs were analyzed, including 108 females and 88 males. vs 11.8%) ( P =0.04).
Expert insights. Personalized for you.
52 
Let's personalize your content